MiR-130b can suppress proliferation of glioma cells through targeting PTEN to regulate AKT pathway

Haitao Niu1, Yang Liu, Yanzhou Wang

  • 1Department of Neurosurgery, Cangzhou Central Hospital, Cangzhou, China.

Abstract

Insights

MicroRNA-130b promotes glioma cell growth by inhibiting PTEN and activating the AKT pathway. Silencing miR-130b suppresses proliferation and induces apoptosis in glioma cells, offering a potential therapeutic strategy.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • Glioma is a common primary brain tumor with complex molecular mechanisms.
  • MicroRNAs (miRNAs) play crucial roles in cancer development and progression.
  • Dysregulation of miR-130b and PTEN has been implicated in various cancers.

Purpose of the Study:

  • To investigate the role of microRNA (miR)-130b in glioma cell proliferation and apoptosis.
  • To determine if miR-130b targets the phosphatase and tensin homolog deleted on chromosome ten (PTEN) gene.
  • To elucidate the underlying molecular mechanisms of miR-130b action in glioma.

Main Methods:

  • miR-130b expression was silenced using miR-130b inhibitors in LN229 glioma cells.
  • Cell proliferation and apoptosis were assessed using CCK-8, colony formation, and flow cytometry assays.
  • PTEN targeting was confirmed via luciferase reporter assays, qRT-PCR, and Western blotting; AKT pathway modulation was also analyzed.

Main Results:

  • miR-130b expression was significantly upregulated in glioma cell lines compared to normal astrocytes.
  • Silencing miR-130b inhibited LN229 cell proliferation and colony formation while increasing apoptosis.
  • miR-130b directly targeted PTEN's 3'-UTR, suppressing its expression; PTEN upregulation upon miR-130b inhibition led to decreased AKT phosphorylation and increased p27.

Conclusions:

  • miR-130b exhibits carcinogenic effects in glioma by promoting cell proliferation and inhibiting apoptosis.
  • Silencing miR-130b suppresses glioma cell growth by upregulating PTEN, subsequently inhibiting the AKT signaling pathway.
  • Targeting miR-130b represents a potential therapeutic strategy for glioma treatment.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.0K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.5K